Affiliation:
1. Department of Organic Chemistry, Center for Research in Biological Chemistry and Molecular Materials, University of Santiago de Compostela, CIQUS, 15705 Santiago de Compostela, Spain
2. Soft Matter & Molecular Biophysics Group, Department of Applied Physics, Faculty of Physics, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain
3. MD.USE Innovations S.L., Edificio Emprendia, 15782 Santiago de Compostela, Spain
Abstract
Artificial intelligence (AI) has the potential to revolutionize the drug discovery process, offering improved efficiency, accuracy, and speed. However, the successful application of AI is dependent on the availability of high-quality data, the addressing of ethical concerns, and the recognition of the limitations of AI-based approaches. In this article, the benefits, challenges, and drawbacks of AI in this field are reviewed, and possible strategies and approaches for overcoming the present obstacles are proposed. The use of data augmentation, explainable AI, and the integration of AI with traditional experimental methods, as well as the potential advantages of AI in pharmaceutical research, are also discussed. Overall, this review highlights the potential of AI in drug discovery and provides insights into the challenges and opportunities for realizing its potential in this field. Note from the human authors: This article was created to test the ability of ChatGPT, a chatbot based on the GPT-3.5 language model, in terms of assisting human authors in writing review articles. The text generated by the AI following our instructions (see Supporting Information) was used as a starting point, and its ability to automatically generate content was evaluated. After conducting a thorough review, the human authors practically rewrote the manuscript, striving to maintain a balance between the original proposal and the scientific criteria. The advantages and limitations of using AI for this purpose are discussed in the last section.
Funder
Spanish Agencia Estatal de Investigación (AEI) and the ERDF
Xunta de Galicia and the ERDF
Centro Singular de Investigación de Galicia
Ministerio de Ciencia, Innovación y Universidades for a “Ramón y Cajal” contract
Xunta de Galicia for a predoctoral contract
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference56 articles.
1. (2022, December 06). OpenAI. ChatGPT (Dec 6 Version) [Large Language Model]. Available online: https://chat.openai.com/chat.
2. (2022, December 06). Plagiarism Detector Software|Anti-Plagiarism Tools|Copyleaks. Available online: https://copyleaks.com.
3. Artificial intelligence in drug discovery and development;Paul;Drug Discov. Today,2021
4. Artificial intelligence: A powerful paradigm for scientific research;Xu;Innovation,2021
5. Zhuang, D., and Ibrahim, A.K. (2021). Deep learning for drug discovery: A study of identifying high efficacy drug compounds using a cascade transfer learning approach. Appl. Sci., 11.
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献